Genedrive Plc


Based on Epistem's proprietary technology, the Genedrive® molecular diagnostic system has been developed as an affordable next generation genotyping and sequence analysis device, providing rapid detection and diagnosis in approximately 45-75 minutes depending on the test. Genedrive® has been designed as a simple-to-use handheld device with high multiplexing capability. 
The first test developed on the Genedrive® is MTB/RIF which allows small/medium laboratories to test for TB thus speeding up diagnosis and treatment and improving prognosis. Genedrive® analyses nucleic acids from fresh or stored samples or biospecimens.